Moreover, in an acute neurodegenerative mouse model, administration of a combination of a TNFR1 antagonist (ATROSAB) and a TNFR2 agonist (EHD2-scTNFR2) was protective against excitotoxicity and rescued cognitive impairments (17). The gene discussed is TNFRSF1A; the disease is Cognitive impairment.